Tyche Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.58M Buy
4,653
+1,564
+51% +$1.6M 0.78% 31
2026
Q1
$2.84M Sell
3,089
-12
-0.4% -$12.2K 0.44% 51
2025
Q4
$3.33M Sell
3,101
-2,015
-39% -$1.93M 0.53% 42
2025
Q3
$3.9M Buy
5,116
+421
+9% +$313K 0.68% 33
2025
Q2
$3.66M Sell
4,695
-129
-3% -$100K 0.74% 31
2025
Q1
$3.98M Sell
4,824
-2,220
-32% -$1.85M 0.86% 25
2024
Q4
$5.44M Buy
7,044
+2,427
+53% +$2.01M 1.15% 18
2024
Q3
$4.09M Buy
4,617
+163
+4% +$147K 0.93% 26
2024
Q2
$4.03M Buy
4,454
+445
+11% +$356K 0.98% 25
2024
Q1
$3.12M Buy
4,009
+923
+30% +$657K 0.76% 27
2023
Q4
$1.8M Buy
+3,086
New +$1.8M 0.43% 46

Other funds holding LLY

Tyche Wealth Partners's LLY Position: Q2 2026 in Review

Tyche Wealth Partners increased its Eli Lilly (LLY) stake by 51% in Q2 2026, buying an estimated $1.6M and bringing the position to 4,653 shares worth $5.58M. The position accounts for 0.78% of the portfolio, ranked #31.

Tyche Wealth Partners first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tyche Wealth Partners held 4,653 shares of Eli Lilly worth $5.58M as of Q2 2026.
  • Tyche Wealth Partners bought 1,564 Eli Lilly shares in Q2 2026, an estimated $1.6M.
  • Eli Lilly made up 0.78% of Tyche Wealth Partners's portfolio in Q2 2026, its #31 holding.
  • Tyche Wealth Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tyche Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.